Your key partner for breakthrough antibody discovery
Mabqi is a dynamic biotechnology company specializing in the discovery and development of human therapeutic antibodies. With a focus on innovative targets, Mabqi leverages proprietary synthetic fully human libraries, including pH-sensitive variants tailored for oncology applications, to drive advancements in antibody therapeutics. Located at 1682, Rue de la Valsière, Grabels, Occitanie 34790, FR, Mabqi offers comprehensive end-to-end discovery solutions, from initial antibody discovery and affinity maturation to optimization and thorough characterization. This ensures that clients receive tailored support and high-quality, developable antibodies that precisely meet their unique needs.
Mabqi is committed to pioneering therapeutic antibodies and provides off-the-shelf antibody assets ready for partnered development and licensing. The company’s expertise spans a wide range of applications, including oncology, immuno-oncology, and inflammation, utilizing cutting-edge technologies such as phage display, yeast display, and in vitro display. Mabqi's capabilities extend to multispecific antibodies, ADCs, and TCEs, offering versatile solutions for complex therapeutic challenges.
As a key partner in breakthrough antibody discovery, Mabqi continues to expand its innovative approaches and refine its technological capabilities. We invite the manager of Mabqi to create a customized and exclusive company showcase and product listing on our platform, enhancing your visibility and fostering new commercial opportunities.
Compare Mabqi with 3 companies in Biotechnology
| Comparison Field |
MabqiMain Company |
IncyteView Profile |
Morgan Prestwich - L...View Profile |
NeoPhore LtdView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2010 | 2017 | |
|
Company Size
|
— | 1,001-5,000 | 11-50 | 2-10 |
|
City
|
Grabels, Occitanie | Wilmington, Delaware | Reigate, Surrey | Cambridge, Cambridgeshire |
|
Country
|
United States | United Kingdom | United Kingdom | |
|
Skills & Keywords
Comparing with main company
|
32 Total Skills
Therapeutic Antibodies
Antibody Discovery
Oncology
Biotechnology
Immuno-oncology
Antibody Development
Drug Conjugates
protein
Antibody affinity maturation
Various Antibody Formats
Naive Libraries
pH sensitive antibodies
Peptide
Conditional activation
Phage display
ion channel
Inflammation
Therapeutic antibodies
GPCR
Infectious
Monoclonal antibodies
Fully Human Antibody Discovery
drug conjugate
Antibody optimization
Yeast display
Multispecific Antibodies
ADC
in vitro display
Human Antibodies
TCE
Bispecific
Synthetic antibody library
|
2 Total
2 Unique
Unique Skills:
Immunology
Targeted Therapy
|
54 Total
1 Common
53 Unique
Match
3%
Common Skills:
Biotechnology
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
Cell Therapy
+47
|
6 Total
1 Common
5 Unique
Match
3%
Common Skills:
Biotechnology
Unique Skills:
Cancer
Drug Discovery
Genetics
Small Molecule Therapeutics
Translational Medicine
|
Other organizations in the same industry
This company is also known as